These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23298605)

  • 1. Lacosamide in pediatric and adult patients: comparison of efficacy and safety.
    Verrotti A; Loiacono G; Pizzolorusso A; Parisi P; Bruni O; Luchetti A; Zamponi N; Cappanera S; Grosso S; Kluger G; Janello C; Franzoni E; Elia M; Spalice A; Coppola G; Striano P; Pavone P; Savasta S; Viri M; Romeo A; Aloisi P; Gobbi G; Ferretti A; Cusmai R; Curatolo P
    Seizure; 2013 Apr; 22(3):210-6. PubMed ID: 23298605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.
    Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H
    Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
    Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
    J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy.
    Farkas MK; Makedonska I; Beller C; Bourikas D; de la Loge C; Dimova S; Floricel F; McClung C; Moseley B; Therriault S; Pina-Garza JE
    Epilepsy Behav; 2024 Oct; 159():109989. PubMed ID: 39216464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome.
    Grosso S; Coppola G; Cusmai R; Parisi P; Spalice A; Foligno S; Verrotti A; Balestri P
    Acta Neurol Scand; 2014 Jun; 129(6):420-4. PubMed ID: 24479878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy.
    Heyman E; Lahat E; Levin N; Berkovitch M; Gandelman-Marton R
    Eur J Paediatr Neurol; 2012 Jan; 16(1):15-9. PubMed ID: 21924653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
    Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
    Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
    Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
    Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
    Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy.
    Gavatha M; Ioannou I; Papavasiliou AS
    Epilepsy Behav; 2011 Apr; 20(4):691-3. PubMed ID: 21406334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
    Chung S; Sperling MR; Biton V; Krauss G; Hebert D; Rudd GD; Doty P;
    Epilepsia; 2010 Jun; 51(6):958-67. PubMed ID: 20132285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
    Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
    Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
    Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
    Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.